103 related articles for article (PubMed ID: 11675825)
1. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
Gnecchi M; Ardissino D
Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
[No Abstract] [Full Text] [Related]
2. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
[TBL] [Abstract][Full Text] [Related]
3. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
[TBL] [Abstract][Full Text] [Related]
4. Quinapril for coronary artery disease.
Seth S; Mohan A
Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
[No Abstract] [Full Text] [Related]
5. Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
Toyofyuku M; Imazu M; Sumii K; Yamamoto H; Hayashi Y; Hiyama K; Kohno N
Atherosclerosis; 2002 Feb; 160(2):339-44. PubMed ID: 11849656
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting.
Okumura K; Kamiya H; Matsui H; Sone T; Kondo J; Tsuboi H; Mukawa H
Atherosclerosis; 2001 Dec; 159(2):527-8. PubMed ID: 11730835
[No Abstract] [Full Text] [Related]
7. [Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
MMW Fortschr Med; 2001 Aug; 143(33-34):58-9. PubMed ID: 11561465
[No Abstract] [Full Text] [Related]
8. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
[TBL] [Abstract][Full Text] [Related]
9. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
[TBL] [Abstract][Full Text] [Related]
10. Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
van Geel PP; Buikema H; Rouleau JL; van Gilst WH
Can J Cardiol; 2003 May; 19(6):701-4. PubMed ID: 12774785
[No Abstract] [Full Text] [Related]
11. [Prevention of ischemic complications. ACE inhibitor helps in endothelial crisis].
MMW Fortschr Med; 1999 Oct; 141(43):58-9. PubMed ID: 10912130
[No Abstract] [Full Text] [Related]
12. [Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
MMW Fortschr Med; 2000 Jan; 142(1-2):54-5. PubMed ID: 11291163
[No Abstract] [Full Text] [Related]
13. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
[TBL] [Abstract][Full Text] [Related]
14. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
[TBL] [Abstract][Full Text] [Related]
15. Clinical restenosis trials: a perspective from the pharmaceutical industry.
Uprichard AC; Texter M; Canter D
Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305
[No Abstract] [Full Text] [Related]
16. [Decreasing blood pressure and more: ACE inhibitor in coronary heart disease?].
MMW Fortschr Med; 2000 Oct; 142(42):50-1. PubMed ID: 11077829
[No Abstract] [Full Text] [Related]
17. Worldwide clinical experience with ACE inhibitors: the role of quinapril. Proceedings of investigators' meeting. Marbella, Spain, June 10-11, 1989.
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S1-63. PubMed ID: 1691401
[No Abstract] [Full Text] [Related]
18. Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Achard JM; Leborgne L; Tribouilloy C; Aldigier JC; Fournier A
Lancet; 2001 Sep; 358(9283):757-8; author reply 758-9. PubMed ID: 11556340
[No Abstract] [Full Text] [Related]
19. [Endothelium research. ACE inhibitor with high vascular affinity].
Riem L
MMW Fortschr Med; 2000 Jun; 142(22):56-7. PubMed ID: 10870387
[No Abstract] [Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
Pepine C
Can J Cardiol; 1998 Jul; 14 Suppl D():23D-26D. PubMed ID: 9713427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
